Please login to the form below
SEC
This page shows the latest SEC news and features for those working in and with pharma, biotech and healthcare.
Celgene boosts CAR-T stake again with Bluebird Bio deal
with the US Securities and Exchange Commission (SEC), plus royalties on sales.
Latest news
-
Theranos and its CEO settle 'massive fraud' charges
Theranos and its CEO settle 'massive fraud' charges. SEC says case is a lesson in truth-telling for those seeking to disrupt an industry. ... Jina Choi, director of the SEC’s San Francisco Regional Office, said: “The Theranos story is an important
-
EU starts investigation of Aspen's cancer drug pricing
This is the first time that the EU authorities have investigated a drugmaker for unjustified price increases, although in the US the Securities &Exchange Commission (SEC) has started an investigation into
-
Valeant's ex-CEO and CFO 'could face criminal charges'
Valeant is already under scrutiny by the Securities &Exchanges Commission (SEC) in the US as well as US Attorney's Offices in New York and Massachusetts, but was understandably tight-lipped
-
GSK draws line under Chinese scandal with $20m SEC settlement
GSK draws line under Chinese scandal with $20m SEC settlement. Brings corruption investigation to an end with commitment to ongoing remediation reports. ... The SEC also said it found that GSK's own control measures on payments to speakers at conferences
-
Valeant shares slide on fears of filing default
Pearson has just returned to work at Valeant after an extended illness, returning just as the company revealed it was facing an investigation by the US Securities &Exchange Commission (SEC), which
More from news
Approximately 2 fully matching, plus 60 partially matching documents found.
Latest Intelligence
-
Creating a successful global compliance programme
The importance of effective compliance programmes was highlighted in the DOJ and SEC’s Resource Guide to the US Foreign Corrupt Practices Act, which describes in detail the hallmarks of a
-
Deal Watch January 2018
investors. However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made
-
US health reforms
In March, the Securities and Exchange Commission (SEC) only narrowly blocked this move.
-
Deal Watch - May 2017
Two months later Abbott asked Alere to cancel the transaction because of a SEC inquiry into accounting issues at Alere and offered $30m to $50m compensation. ... Alere rejected the offer. Abbott had been aware of the SEC inquiry before the deal was signed
-
On the road with the millennial HCP
Yeah I'll put Andy on. Just hang on a sec, he's just sorting our next lift.”.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
Celgene boosts CAR-T stake again with Bluebird Bio deal
with the US Securities and Exchange Commission (SEC), plus royalties on sales.
-
RSA announces three new UK hires
In 2009, de Luis moved to the UK with SEC Recruitment and spent three years focussing on the Spanish pharmaceutical market across a number of functional areas.
-
Scottish cabinet reshuffle sees Alex Neil made health secretary
Commenting on Twitter, Sturgeon said: “ It has been a privilege to have been Health Sec[retary] - my thanks to all the wonderful people I have worked with.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
SALES ACCELERANT
We help companies to engage prim/sec care healthcare professionals more efficiently and effectively to drive sales growth.
-
SEC Pharma
SEC Pharma. Whether its working with pharmaceutical, CRO, biotech organisations medical communications agencies covering Clinical Research, Regulatory Affairs, Biometrics, Pharmacovigilance, Medical Affairs and medical communications; supporting blue
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
-
Account Manager
-
Negotiable
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Sudler London - Account Director
-
Competitive
- Senior Writer, Healthcare Advertising, London
-
Excellent package
-
Senior Medical Writer
-
Salary is DOE
-
Associate Scientific Director
-
Salary TBC
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Account Director or Senior Account Director
-
Salary TBC
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
-
Systematic Review Lead- London
-
Negotiable
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
Subscribe to our email news alerts
- Innovate UK supports AI drug discovery project worth £1m
- Nurturing the growth mindset: The need for ongoing professional development in strategic medical communications
- Superhuman editor wins promotion at Porterhouse Medical
- Kymriah rejected in DLBCL - but NICE wants to keep talking about cost effectiveness
- Biotech leaders jump into US free speech debate
- Viking throws down gauntlet in NASH battle
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
